JANX

Janux Therapeutics, Inc.

Healthcare›Biotechnology|NASDAQ Global Market|US

Price

$14.84

Market Cap

$902.74M

Beta

2.88

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+68.87%

EPS Growth (YoY)-42.97%

Revenue CAGR 3Y+27.57%

P/E Ratio0.0

PEG Ratio—

FCF Yield+0.00%

Debt / Equity0.04

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for JANX.